Daniel Schneider
Chief Executive Officer bei PHOTOCURE ASA
Vermögen: 508 182 $ am 31.03.2024
Aktive Positionen von Daniel Schneider
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHOTOCURE ASA | Chief Executive Officer | 01.11.2018 | - |
| President | 01.11.2018 | - |
Karriereverlauf von Daniel Schneider
Ehemalige bekannte Positionen von Daniel Schneider
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ABLYNX | Chief Executive Officer | - | - |
Ausbildung von Daniel Schneider
| University of Washington | Masters Business Admin |
| St. Louis University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 2 |
| Norwegen | 2 |
| Spanien | 2 |
Operativ
| Chief Executive Officer | 2 |
| President | 1 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Börse
- Insiders
- Daniel Schneider
- Erfahrung
